(Q41731064)

8 October 2017

Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A466868

4 July 2022

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

27 May 2023

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

27 May 2023

author name string

E. M. Faed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A466868

4 July 2022

E. G. McQueen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A466868

4 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=466868

4 July 2022

publication date

1 May 1979

1 reference

full work available at URL

8 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1681.1979.tb01248.x

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.1979.tb01248.x/fullpdf

27 May 2023

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Clinical and Experimental Pharmacology and Physiology

27 May 2023

published in

1 reference

8 October 2017

6

1 reference

8 October 2017

267-273

1 reference

8 October 2017

3

1 reference

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

8 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1979.TB01248.X

Assay of clofibrate in human serum by gas chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1979.TB01248.X

Clofibrate-lnduced acute muscular syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1979.TB01248.X

A gas-liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to an ultra violet method

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Journal of Pharmacology and Experimental Therapeutics

27 May 2023

3

200

33

Cayen M.N.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Letter: Acute-on-chronic renal failure precipitated by clofibrate

27 May 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Serum Clofibrate Concentrations in Patients on Continuous Medication

27 May 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Separation of two conjugates of clofibric acid (CPIB) found in the urine of subjects taking clofibrate

27 May 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

27 May 2023

8

26

2076

Haselbarth V.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Acute Muscular Syndrome Associated with Administration of Clofibrate

27 May 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Clofibrate, Serum Enzymes, and Muscle Pain

27 May 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate

27 May 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1440-1681.1979.TB01248.X

27 May 2023

Identifiers

1 reference

8 October 2017

1 reference